Hypertension is identified in the protocol as a major, modifiable contributor to cardiovascular disease in low- and middle-income countries. The authors highlight central adiposity and physical inactivity as important drivers of elevated cardiovascular risk. They note that wheelchair users are a structurally marginalised population who may experience prolonged sitting and altered body composition, but that epidemiological data comparing cardiovascular risk markers by mobility status in rural South African settings are limited.
The study is set in the Thulamela Municipality, Limpopo Province, and aims to address the gap in context-specific data on blood pressure, central adiposity, physical activity, and sedentary behaviour between people who use wheelchairs and ambulatory adults in that rural area.
The protocol states the primary objective is to compare blood pressure profiles, central adiposity (measured by waist circumference), physical activity levels, and sedentary behaviour between wheelchair users and ambulatory adults in Thulamela Municipality. A secondary objective is to determine whether mobility status is independently associated with hypertension after accounting for clinical and demographic confounders.
Design: The study adopts an analytical, community-based cross-sectional design.
Sample: The planned total sample size is N = 210 adults, comprising n = 70 wheelchair users and n = 140 ambulatory controls. Recruitment will use purposive and convenience sampling strategies conducted within rural networks.
Setting: Recruitment and data collection will take place in the Thulamela Municipality, Limpopo Province, South Africa.
Measurements and standardisation: To ensure comparability across mobility groups, the protocol specifies seated blood pressure measurements and seated waist circumference assessments for all participants. The seated approach is applied to standardise measurement conditions for both wheelchair users and ambulatory adults.
Physical activity and sedentary behaviour: Physical activity and sedentary durations will be captured using the Leisure Time Physical Activity Questionnaire for Spinal Cord Injury (LTPAQ-SCI) for wheelchair users and the International Physical Activity Questionnaire Short Form (IPAQ-SF) for ambulatory participants. The protocol indicates these instrument-specific outputs will be harmonised mathematically into weekly minutes of moderate-to-vigorous physical activity (MVPA) to facilitate comparable quantitative analysis.
Sampling considerations: The protocol indicates recruitment will rely on local rural networks and convenience approaches; further operational details of recruitment procedures, eligibility criteria, or exclusion criteria were not reported in the source abstract.
Between-group comparisons: The protocol specifies that inter-group differences will be evaluated using independent samples t-tests for normally distributed continuous variables or Mann–Whitney U tests for non-normally distributed variables.
Multivariable modelling: To assess whether mobility status is independently associated with hypertension, the authors plan to use multivariate binary logistic regression models. These models will control for potential confounding clinical and demographic factors. The abstract does not list the specific covariates planned for inclusion in the regression models.
Outcome harmonisation: Physical activity measures from the LTPAQ-SCI and IPAQ-SF will be converted to a common metric—weekly minutes of MVPA—which will be used in comparative and regression analyses.
The authors declare that they have followed relevant ethical guidelines and will obtain necessary institutional review board and ethics committee approvals prior to commencing recruitment and data collection. The Institutional Research Ethics Committee (IREC) at the University of Zululand is named as the review body, and the protocol indicates additional approval will be sought from the relevant provincial health authorities.
The authors confirm that participant consent procedures and appropriate institutional forms will be used and archived. The preprint includes an explicit competing interest statement: the authors have declared no competing interests.
The manuscript is posted as a medRxiv preprint and the authors emphasise that it has not been peer reviewed; they note that the report should not be used to guide clinical practice until it has undergone appropriate evaluation.
The abstract states that no datasets were generated or analysed at the time of posting. It indicates that all relevant data produced by the study will be made available upon study completion, subject to applicable ethical approvals and data-protection requirements. No further details about data sharing platforms, timelines, or access procedures are provided in the source abstract.
This protocol is available as a medRxiv preprint (posted September 20, 2026, as indicated in the source metadata) with a DOI assigned. The preprint is distributed under a CC-BY 4.0 International license and remains the copyright of the authors/funders while medRxiv is licensed to display the content in perpetuity.
The authors list institutional affiliations for correspondence and declare adherence to reporting guidelines and registration requirements for prospective interventional studies where applicable. Specific trial registration identifiers or additional operational details beyond the abstract were not reported in the source.